These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7784153)

  • 21. [Proton therapy in Japan].
    Schwartz LH; Tatsuzaki H
    Bull Cancer Radiother; 1995; 82(3):279-82. PubMed ID: 8554877
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Normal liver sparing by proton beam therapy for hepatocellular carcinoma: Comparison with helical intensity modulated radiotherapy and volumetric modulated arc therapy.
    Kim JY; Lim YK; Kim TH; Cho KH; Choi SH; Jeong H; Kim DW; Park JH; Shin DH; Lee SB; Kim SS; Kim JY; Kim DY; Park JW
    Acta Oncol; 2015 Nov; 54(10):1827-32. PubMed ID: 25765526
    [No Abstract]   [Full Text] [Related]  

  • 23. Dose-volumetric parameters predicting radiation-induced hepatic toxicity in unresectable hepatocellular carcinoma patients treated with three-dimensional conformal radiotherapy.
    Kim TH; Kim DY; Park JW; Kim SH; Choi JI; Kim HB; Lee WJ; Park SJ; Hong EK; Kim CM
    Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):225-31. PubMed ID: 17056199
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical evaluation of heavy-particle radiotherapy using dose volume histogram (DVH)].
    Terahara A; Nakano T; Tsujii H
    Gan To Kagaku Ryoho; 1998 Jan; 25(1):34-42. PubMed ID: 9464327
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Proton beam therapy].
    Ogino T
    Gan To Kagaku Ryoho; 2006 Apr; 33(4):450-4. PubMed ID: 16612152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proton beam therapy for hepatocellular carcinoma adjacent to the porta hepatis.
    Mizumoto M; Tokuuye K; Sugahara S; Nakayama H; Fukumitsu N; Ohara K; Abei M; Shoda J; Tohno E; Minami M
    Int J Radiat Oncol Biol Phys; 2008 Jun; 71(2):462-7. PubMed ID: 18243571
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Initial clinical experience of proton therapy at Shizuoka Cancer Center].
    Murayama S; Fuji H; Yamashita H; Futami Y; Numano M; Harada H; Kamata M; Nishimura T
    Nihon Igaku Hoshasen Gakkai Zasshi; 2005 Oct; 65(4):424-31. PubMed ID: 16334397
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biologic susceptibility of hepatocellular carcinoma patients treated with radiotherapy to radiation-induced liver disease.
    Cheng JC; Wu JK; Lee PC; Liu HS; Jian JJ; Lin YM; Sung JL; Jan GJ
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1502-9. PubMed ID: 15590181
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proton beam therapy for hepatocellular carcinoma: a retrospective review of 162 patients.
    Chiba T; Tokuuye K; Matsuzaki Y; Sugahara S; Chuganji Y; Kagei K; Shoda J; Hata M; Abei M; Igaki H; Tanaka N; Akine Y
    Clin Cancer Res; 2005 May; 11(10):3799-805. PubMed ID: 15897579
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proton beam therapy for large hepatocellular carcinoma.
    Sugahara S; Oshiro Y; Nakayama H; Fukuda K; Mizumoto M; Abei M; Shoda J; Matsuzaki Y; Thono E; Tokita M; Tsuboi K; Tokuuye K
    Int J Radiat Oncol Biol Phys; 2010 Feb; 76(2):460-6. PubMed ID: 19427743
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of lipiodol agent on proton beam range in radiotherapy planning using computed tomography for hepatocellular carcinoma.
    Shin D; Kim TH; Park SY; Kwak J; Moon SH; Yoon M; Lee SB; Park S; Shin KH; Kim DY; Cho KH; Park JW; Kim CM
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):687-94. PubMed ID: 18448269
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cumulative dose of radiation therapy of hepatocellular carcinoma patients and its deterministic relation to radiation-induced liver disease.
    Huang P; Yu G; Kapp DS; Bian XF; Ma CS; Li HS; Chen JH; Liang YQ; Zhang Y; Qin SH; Xie YQ; Yang Y; Yin Y; Xing L; Li DW
    Med Dosim; 2018 Autumn; 43(3):258-266. PubMed ID: 29198389
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of adverse effects of proton and X-ray chemoradiotherapy for esophageal cancer using an adaptive dose-volume histogram analysis.
    Makishima H; Ishikawa H; Terunuma T; Hashimoto T; Yamanashi K; Sekiguchi T; Mizumoto M; Okumura T; Sakae T; Sakurai H
    J Radiat Res; 2015 May; 56(3):568-76. PubMed ID: 25755255
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A prospective study of hypofractionated proton beam therapy for patients with hepatocellular carcinoma.
    Fukumitsu N; Sugahara S; Nakayama H; Fukuda K; Mizumoto M; Abei M; Shoda J; Thono E; Tsuboi K; Tokuuye K
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):831-6. PubMed ID: 19304408
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A case of hepatocellular carcinoma initially treated by carbon ions, followed by protons for marginal recurrence with portal thrombus.
    Mayahara H; Oda Y; Kawaguchi A; Kagawa K; Murakami M; Hishikawa Y; Igaki H; Tokuuye K; Abe M
    Radiat Med; 2005 Nov; 23(7):513-9. PubMed ID: 16485544
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is there a role for proton therapy in the treatment of hepatocellular carcinoma? A systematic review.
    Dionisi F; Widesott L; Lorentini S; Amichetti M
    Radiother Oncol; 2014 Apr; 111(1):1-10. PubMed ID: 24560761
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clearance of parenchymal tumors following radiotherapy: analysis of hepatocellular carcinomas treated by proton beams.
    Ohara K; Okumura T; Tsuji H; Min M; Tatsuzaki H; Chiba T; Tsujii H; Akine Y; Itai Y
    Radiother Oncol; 1996 Dec; 41(3):233-6. PubMed ID: 9027939
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proton beam therapy for tumors of the upper abdomen.
    Raldow A; Lamb J; Hong T
    Br J Radiol; 2020 Mar; 93(1107):20190226. PubMed ID: 31430202
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and toxicity related to treatment of hepatocellular carcinoma with 90Y-SIR spheres: radiobiologic considerations.
    Strigari L; Sciuto R; Rea S; Carpanese L; Pizzi G; Soriani A; Iaccarino G; Benassi M; Ettorre GM; Maini CL
    J Nucl Med; 2010 Sep; 51(9):1377-85. PubMed ID: 20720056
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Efficacy of proton irradiation for HCC].
    Matsuzaki Y; Tanaka N; Chiba T
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():659-64. PubMed ID: 11762031
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.